ImportRefusal LogoImportRefusal

Laboratorios PiSA, S.A. de C.V. (Planta Calle 7)

⚠️ High Risk

FEI: 3005440755 • Guadalajara, Jalisco • MEXICO

FEI

FEI Number

3005440755

📍

Location

Guadalajara, Jalisco

🇲🇽

Country

MEXICO
🏢

Address

Calle 7 No. 1308, Col. Zona Industrial, Guadalajara, Jalisco, Mexico

High Risk

FDA Import Risk Assessment

65.8
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

40
Total Refusals
9
Unique Violations
5/13/2025
Latest Refusal
11/6/2009
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
59.7×30%
Recency
86.5×20%
Frequency
25.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7529×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

2565×

INCONSPICU

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

2185×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

114×

UNSAFE COL

The article appears to be, or to bear or contain a color additive which is unsafe within the meaning of Section 721(a).

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2743×

COLOR LBLG

The article appears to contain an artificial coloring and it fails to bear labeling stating that fact.

4723×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

Refusal History

DateProductViolationsDivision
5/13/2025
60LDP99ANALGESIC, N.E.C.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/2/2024
41GHT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Division of Southwest Imports (DSWI)
5/13/2024
63BCE25FLUTICASONE PROPIONATE (BRONCHODILATOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/13/2024
62FCL53MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/21/2024
60QAY07LIDOCAINE
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/19/2024
60QDY07LIDOCAINE
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/7/2023
56DCL06AMIKACIN SULFATE (AMINOGLYCOSIDES)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/7/2023
64LCY20DEXAMETHASONE SODIUM PHOSPHATE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/3/2023
60LDK69TRAMADOL HCL (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/28/2023
64LCK19DEXAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/7/2023
62GBK18DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/19/2022
66VCB99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2022
64LDK19DEXAMETHASONE (GLUCOCORTICOID)
472NO ENGLISH
473LABELING
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/17/2022
54YEY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
472NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/27/2022
64NCK07IRON DEXTRAN (INJ) (HEMATINIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/27/2022
56BCK10BENZYLPENICILLOYL-POLYLYSINE (PENICILLIN, SYNTHETICALLY PRODUCED)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/20/2022
62GCY94KETOROLAC TROMETHAMINE (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/16/2021
41GHT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
274COLOR LBLG
Division of Southwest Imports (DSWI)
11/30/2021
54ABA11HYDROXOCOBALAMIN (VITAMIN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/12/2021
64LDL19DEXAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/31/2021
41GHT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
274COLOR LBLG
Division of Southwest Imports (DSWI)
6/15/2021
65CDY07LEVOCARNITINE (NUTRIENT/TONIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/1/2021
64LDB20DEXAMETHASONE SODIUM PHOSPHATE (GLUCOCORTICOID)
27DRUG GMPS
Division of Southeast Imports (DSEI)
4/17/2020
64LDY19DEXAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/28/2019
61CCL99ANTI-ANEMIC, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/26/2019
56DDY06AMIKACIN SULFATE (AMINOGLYCOSIDES)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/16/2019
62GCY94KETOROLAC TROMETHAMINE (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/16/2019
64LCY19DEXAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/4/2017
65CAY07LEVOCARNITINE (NUTRIENT/TONIC)
472NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/28/2017
61PCY55METFORMIN HCL (ANTI-DIABETIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/4/2017
61PCL35INSULIN HUMAN/INSULIN SUSP ISOPHANE HUMA (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/28/2016
62GDK99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/29/2013
61PCA31GLIMEPIRIDE (ANTI-DIABETIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/22/2013
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
8/9/2011
41GGT03ORAL REHYDRATION PRODUCTS
218LIST INGRE
256INCONSPICU
274COLOR LBLG
Southwest Import District Office (SWI-DO)
8/9/2011
41GGT03ORAL REHYDRATION PRODUCTS
218LIST INGRE
256INCONSPICU
Southwest Import District Office (SWI-DO)
8/9/2011
41GGT03ORAL REHYDRATION PRODUCTS
218LIST INGRE
256INCONSPICU
Southwest Import District Office (SWI-DO)
8/9/2011
41GGT03ORAL REHYDRATION PRODUCTS
218LIST INGRE
256INCONSPICU
Southwest Import District Office (SWI-DO)
8/9/2011
41GGT03ORAL REHYDRATION PRODUCTS
218LIST INGRE
256INCONSPICU
Southwest Import District Office (SWI-DO)
11/6/2009
78EXGBAG, URINE COLLECTING, URETEROSTOMY
118NOT LISTED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Laboratorios PiSA, S.A. de C.V. (Planta Calle 7)'s FDA import refusal history?

Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) (FEI: 3005440755) has 40 FDA import refusal record(s) in our database, spanning from 11/6/2009 to 5/13/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratorios PiSA, S.A. de C.V. (Planta Calle 7)'s FEI number is 3005440755.

What types of violations has Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) received?

Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) has been cited for 9 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) come from?

All FDA import refusal data for Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.